Tumour cell motility and attachment are crucial requirements in the formation of metastatic lesions. These properties are affected by a number of cytokines including hepatocyte growth factor/scatter factor (HGF/SF) and several immunoregulatory proteins, including interleukin-12 (IL-12). Although IL-12 has been reported to exhibit potent anti-tumour effects in vivo, a direct effect of IL-12 on cancer cells has not been reported. We show here that IL-12 directly inhibited the attachment of the human colon cancer cell lines HRT18, HT29 and HT115 to Matrigel, HGF/SF-stimulated cell motility and HGF/SF-induced cell invasion through a reconstituted basement membrane. IL-12 did not affect the growth of these cell lines. Flow cytometry, Western analysis and immunohistochemistry revealed an up-regulation of E-cadherin cell-surface adhesion molecules. These direct effects of IL-12 on colon cancer cells suggest a potentially important role for IL-12 in metastasis.
Similar content being viewed by others
References
Liotta LA, 1987, Biochemical mechanisms of tumour invasion and metastasis. Clin Physiol Biochem, 5, 190–99.
Schiffmann E, 1990, Motility as a principal requirement for metastasis. Cancer Invest, 8, 673–4.
Hart IR, Goode, NT and Wilson RE, 1989, Molecular aspects of the metastatic cascade. Biochim Biophys Acta, 989, 65–84.
Liotta LA and Stracke ML, 1988, Tumour invasion and metastasis: biochemical mechanisms. Cancer Treat Res, 40, 223–8.
Fidler IJ, Gersten DM and Hart IR, 1978, The biology of cancer invasion and metastasis. Adv Cancer Res, 28, 149–205.
Takeichi M, 1988, The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development, 102, 639–55.
Takeichi M, 1991, Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451–5.
Shiozaki H, Kobayashi K, Inoue M, et al. 1993, Expression of e-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 53, 1696–701.
Doki Y, Shiozaki H, Tahara H, et al. 1993, Correlation between e-cadherin expression and invasiveness in vitro in a human oesophageal cancer cell line. Cancer Res, 53, 3421–6.
Mayer B, Johnson JP, Leitl F, et al. 1993, e-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res, 53, 1690–5.
Umbas R, Schlaken JA, Aalders, TW, et al. 1992, Expression of the cellular adhesion molecule e-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 52, 5104–9.
Shiozaki H, Tahara H, Oka H, et al. 1991, Expression of immunoreactive e-cadherin adhesion molecules in human cancers. Am J Pathol, 139, 17–23.
Bongiorno PF, Kasspooles MAl-, et al. 1995, e-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. Br J Cancer, 71, 166–72.
Brunda MJ, Luistro L, Warrier RR, et al. 1993, Antitumour and antimetastatic activity of interleukin-12 against murine tumours. J Exp Med, 178, 1223–30.
Truitt GA, Bontempo JW, Stern LL, et al. 1989, Efficacy and toxicology elicited by recombinant interferons alpha and gamma when administered in combination to tumour-bearing mice. Biotechnol Ther, 1, 1–8.
Kobayashi M, Fitz L, Ryan M, et al. 1989, Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med, 170, 827–45.
Stern AS, Podalski FJ, Hulmes JD, et al. 1990, Purification to homogeneity and partial characterisation of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA, 87, 6808–12.
D'Andrea A, Rengaraju M, Valiante NM, et al. 1992, Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med, 176, 1387–98.
Gatley MK, Desai BB, Wolitzki AG, et al. 1991, Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol, 147, 874–82.
Wolf SF, Temple PA, Kobayashi M, et al. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J Immunol, 146, 3074–81.
Chehimi J, Starr SE, Frank I, et al. 1992, Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J Exp Med, 175, 789–96.
Bancroft GJ, Schreiber RD and Unanue ER, 1991, Natural immunity: a T-cell independent pathway of macrophage activation, defined in the scid mouse. Immunol Rev, 124, 5–24.
Andrews JVR, Schoof DD, Bertagnolli MM, et al. 1993, Immunomodulatory effects of interleukin-12 on human tumour-infiltrating lymphocytes. J Immunol, 14, 1–10.
Chan SH, Perussia B, Gupta JW, et al. 1991, Induction of IFN-y production by NK cell stimulatory factor (NKSF): characterisation of the responder cells and synergy with other inducers. J Exp Med, 173, 869–75.
Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG, 1993, Tumour suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA, 90, 232–6.
Rosen EM, Meromsky L, Setter E, Vinter DW and Goldberg I, 1990, Quantitation of cytokine-stimulated migration of endothelium and epithelium by a new assay using microcarrier beads. Exp Cell Res, 186, 22–31.
Furukawa T, Watanabe M, Kubota T, et al. 1993, Significance of in vitro attachment of human colon cancers to extracellular matrix proteins in experimental and clinical liver metastasis. J Surg Oncol, 53, 10–6.
Jiang WG, Hiscox S, Hallett MB, et al. 1995, Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer, 71, 744–52.
Tada H, Shiho O, Kuroshima K, Koyama M and Tsukamoto K, 1986, An improved colorimetric assay for interleukin-2. J Immunol Methods, 93, 157–65.
Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumour cells. Cancer Res, 47, 3239–45.
Parish CR, Jakobsen KB and Coombe DR, 1992, A basement membrane permeability assay which correlates with the metastatic potential of tumour cells. Int J Cancer, 52, 3239–45.
Donaldson GA and Welch JP, 1974, Management of cancer of the colon. Surg Clin N Amer, 54, 713–30.
Robertson MJ, Soiffer RJ, Wolf SF, et al. 1992, Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med, 175, 779–88.
Tahara H, Zeh HJ, Storkus WJ, et al. 1994, Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumour growth and induce antitumour immunity to a murine melanoma in vivo. Cancer Res, 54, 182–9.
Jiang WG, Lloyds D, Puntis MCA, Nakamura T and Hallett MB, 1993, Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Metastasis, 11, 235–42.
Jiang WG, Hallett MB and Puntis MCA, 1993, Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg, 80, 1368–73.
Nakamura T, Nawa K and Ichihara A, 1984, Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commum, 122, 1450–59.
Stoker M, Gheradi E, Perryman M and Gray J, 1987, Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature, 327, 239–42.
Weidner KM, Arakaki N, Hartmann G, Birchmeier W, et al. 1991, Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl' Acad Sci USA, 88, 7001–5.
Gherardi E and Stoker M, 1990, Hepatocyte and scatter factor (Letter). Nature, 346, 228.
Di Renzo MF, Olivero M and Ferro S, 1992, Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene, 7, 2549–53.
Ebert M, Yokoyama M, Friess H, Buchler MW and Kore M, 1994, Coexpression of the c-met protooncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res, 54, 5775–8.
Rong S, Bodescot M, Blair D, Dunn J, 1992, Tumorigenicity of the met protooncogene and the gene for hepatocyte growth factor. Mol Cell Biol, 12, 5152–8.
Behrens J, Weidner KM, Frixen UH, et al. 1991, The role of e-cadherin and scatter factor in tumour invasion and cell motility. In: Cell Motility Factors, Goldberg ID, ed. Birkharser: Basle, pp. 109–26.
Bowie GL, Caslin AW, Roland NJ, et al. 1993, Expression of cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol, 18(3), 196–201.
Shimoyama Y, Hirohashi S, Hirano S, et al. 1989, Adherin cell adhesion molecules in human epithelial tissues and carcinomas. Cancer Res, 49, 2128–33.
Frixen UH, Behrens J, Sachs M et al. 1991, e-cadherinmediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol, 113, 173–85.
Desai BB, Quin PM, Wolitzky AG, et al. 1992, IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol, 148, 3125–32.
Chua AO, Chizzonite R, Desai BB, et al. 1994, Expression cloning of a human IL-12 receptor component. J Immunol, 153, 128–36.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hiscox, S., Hallett, M.B., Puntis, M.C.A. et al. Inhibition of cancer cell motility and invasion by interleukin-12. Clin Exp Metast 13, 396–404 (1995). https://doi.org/10.1007/BF00121916
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00121916